Living With Chronic Lymphocytic Leukemia (CLL)
May 18, 2022
Topics Covered
We invite you to learn more about:
- Treatment goals for a chronic disease
- New and emerging therapies for CLL
- Side-effects management
- The importance of open communication with your healthcare team
Program Materials
Speaker
Stephen E. Spurgeon, MD
Associate Professor of Medicine
School of Medicine
Oregon Health & Science University
Hematology/Oncology
Portland, OR
Program Support
Support for this program is provided by Genentech, Inc. & Biogen, Eli Lilly and Company, and Pharmacylics, An AbbVie Company & Janssen Biotech.